We are live on
!
Find out more
AbCellera Biologics
ABCL
ABCL
86 hedge funds and large institutions have $2.42B invested in AbCellera Biologics in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
126% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 19
65% more call options, than puts
Call options by funds: $2.35M | Put options by funds: $1.42M
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
39% more funds holding
Funds holding: 62 → 86 (+24)
1.16% more ownership
Funds ownership: 25.65% → 26.81% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
12% less capital invested
Capital invested by funds: $2.74B → $2.42B (-$324M)
Holders
86
Holders Change
+24
Holders Change %
+38.71%
% of All Funds
1.51%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
43
Increased
20
Reduced
14
Closed
19
Calls
$2.35M
Puts
$1.42M
Net Calls
+$932K
Net Calls Change
+$932K
Top Buyers
Top Sellers
| 1 |
AWG
Alpha Wave Global
New York
|
-$54.9M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$24.1M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$20.1M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$18.4M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$18.3M |
